Machine learning models of ischemia/hemorrhage in moyamoya disease and analysis of its risk factors

被引:9
作者
Chen, Zhongjun [1 ,3 ]
Luo, Haowen [2 ]
Xu, Lijun [1 ]
机构
[1] Nanchang Univ, Affiliated Hosp 2, Dept Neurol, Nanchang 330006, Jiangxi, Peoples R China
[2] Nanchang Univ, Affiliated Hosp 2, Med Big Data Ctr, Nanchang 330006, Jiangxi, Peoples R China
[3] Shangrao Peoples Hosp, Dept Neurol, Shangrao 334000, Jiangxi, Peoples R China
关键词
LR; XGboost; SVM; Model; MMD; CLINICAL-FEATURES;
D O I
10.1016/j.clineuro.2021.106919
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Object: This study aimed to determine the risk factors of ischemic/hemorrhagic stroke in patients suffering moyamoya disease (MMD), as well as to compare the effects of six analysis methods. Methods: In the present retrospective study, the data originated from the database of Jiang Xi Province Medical Big Data Engineering & Technology Research Center. In addition, the information of patients with MMD that were admitted to the second affiliated hospital of Nanchang university from January 1st, 2012 to December 31st, 2019 was acquired. Six different machine learning methods were adopted to build the models, and XGboost, Logistic regression (LR) and Support vector machine (SVM) models were adopted to determine the risk factors of ischemic/hemorrhagic stroke in patients with MMD because of their excellent performance. Next, the effects of the built models were compared and validated in internal and independent external validation sets. The external validation set involving 204 cases from January 1st, 2018 to December 31st, 2019. Result: On the whole, 790 patients with MMD were screened, i.e., 397 patients with cerebral infarction and 393 patients with cerebral hemorrhage. In the internal validation set, XGboost model exhibited significant discrimination (AUC>0.75), with its area under the curve (AUC) reaching 0.874 (95% CI: 0.859, 0.889). Compared with the LR and SVM models, the XGboost model in the internal validation set achieved the improved accuracy by 3.2% and 3.1%, respectively, whereas no significant difference was identified. Conclusion: XGboost model could be more efficient in analyzing the risk factors of ischemic/hemorrhagic stroke in patients with MMD; the risk factors of hemorrhagic stroke in MMD might be closely related to Suzuki stages, presence of an aneurysm, rural residence, hospitalization times and age of onset.
引用
收藏
页数:8
相关论文
共 27 条
[1]   Permutation importance: a corrected feature importance measure [J].
Altmann, Andre ;
Tolosi, Laura ;
Sander, Oliver ;
Lengauer, Thomas .
BIOINFORMATICS, 2010, 26 (10) :1340-1347
[2]  
Amin-Hanjani Sepideh, 2014, Surg Neurol Int, V5, pS155, DOI 10.4103/2152-7806.134812
[3]   Novel epidemiological features of moyamoya disease [J].
Baba, T. ;
Houkin, K. ;
Kuroda, S. .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2008, 79 (08) :900-904
[4]   Big Data and Machine Learning in Health Care [J].
Beam, Andrew L. ;
Kohane, Isaac S. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 319 (13) :1317-1318
[5]   Testosterone improves spatial memory in men with Alzheimer disease and mild cognitive impairment [J].
Cherrier, MM ;
Matsumoto, AM ;
Amory, JK ;
Asthana, S ;
Bremner, W ;
Peskind, ER ;
Raskind, MA ;
Craft, S .
NEUROLOGY, 2005, 64 (12) :2063-2068
[6]   Recurrent Subdural Hematoma From a Pseudoaneurysm at the Cortical Branch of the Middle Cerebral Artery After Mild Head Injury-Case Report [J].
Cho, Won-Sang ;
Batchuluun, Batbold ;
Lee, Seung Jin ;
Kang, Hyun-Seung ;
Kim, Jeong Eun .
NEUROLOGIA MEDICO-CHIRURGICA, 2011, 51 (03) :217-221
[7]   Increased serum production of soluble CD163 and CXCL5 in patients with moyamoya disease: Involvement of intrinsic immune reaction in its pathogenesis [J].
Fujimura, Miki ;
Fujimura, Taku ;
Kakizaki, Aya ;
Sato-Maeda, Mika ;
Niizuma, Kuniyasu ;
Tomata, Yasutake ;
Aiba, Setsuya ;
Tominaga, Teiji .
BRAIN RESEARCH, 2018, 1679 :39-44
[8]   Clinical features, surgical treatment, and outcome of intracranial aneurysms associated with moyamoya disease [J].
Ge, Peicong ;
Ye, Xun ;
Zhang, Qian ;
Liu, Xingju ;
Deng, Xiaofeng ;
Zhao, Meng ;
Wang, Jia ;
Wang, Rong ;
Zhang, Yan ;
Zhang, Dong ;
Zhao, Jizong .
JOURNAL OF CLINICAL NEUROSCIENCE, 2020, 80 :274-279
[9]  
Ge PC, 2017, WORLD NEUROSURG, V106, P224, DOI [10.1016/J.WNEU.2017.06.145, 10.1016/j.wneu.2017.06.145]
[10]   Socioeconomic and demographic disparities of moyamoya disease in the United States [J].
Ghaffari-Rafi, Arash ;
Ghaffari-Rafi, Shadeh ;
Leon-Rojas, Jose .
CLINICAL NEUROLOGY AND NEUROSURGERY, 2020, 192